Marksans Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve quarterly results for the Quarter ....
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has informed the exchanges that its Board of Directors will meet on November 13, 2025 to consider and approve the unaudited financial results (both standalone and consolidated) for the quarter and half year ended September 30, 2025. The trading window for designated persons and their immediate relatives has been closed from October 1, 2025 and will remain closed until November 15, 2025 (48 hours after the results announcement). This is a routine regulatory filing under SEBI Listing Regulations, and no financial figures or outcomes are disclosed at this stage.
This is a standard advance notice and carries no direct impact on the stock price. Investors should watch the November 13 results announcement for actual Q2 FY26 performance, which will be the next actionable data point.